The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer

BACKGROUND: Activating mutations in RAS are present in the majority of pancreatic cancer cases and represent an ideal therapeutic target. Reolysin is a proprietary formulation of oncolytic reovirus that is currently being evaluated in multiple clinical trials due to its ability to selectively replic...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Mahalingam, Devalingam, Patel, Sukeshi, Nuovo, Gerard, Gill, George, Selvaggi, Giovanni, Coffey, Matt, Nawrocki, Steffan T.
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496814/
https://ncbi.nlm.nih.gov/pubmed/26156229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1518-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items